Iris Morr
Impact in
- Genetics top 10%
- Virus-based gene therapy research
-
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
Papers in
- Co-authors
- Uwe Haberkorn (11 shared papers)Annette Altmann (10 shared papers)G. van Kaick (9 shared papers)Franz Oberdorfer (6 shared papers)Shiming Jiang (3 shared papers)Matthias E. Bellemann (3 shared papers)J. Blatter (3 shared papers)Uwe Haberkorn (3 shared papers)
In The Last Decade
Iris Morr
14 papers receiving 521 citations
Peers
Comparison fields: 5 of 51
- Genetics 208
- Radiology, Nuclear Medicine and Imaging 140
- Biotechnology 56
- Cancer Research 79
- Molecular Biology 213
Countries citing papers authored by Iris Morr
This map shows the geographic impact of Iris Morr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Morr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Morr more than expected).
Fields of papers citing papers by Iris Morr
This network shows the impact of papers produced by Iris Morr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Morr. The network helps show where Iris Morr may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Morr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. | 2001 | 97 |
| 2 | Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. | 1996 | 81 |
| 3 | Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. | 1997 | 63 |
| 4 | Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. | 1994 | 53 |
| 5 | PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. | 1997 | 45 |
| 6 | 1998 | 41 | |
| 7 | 2001 | 35 | |
| 8 | 1998 | 30 | |
| 9 | 2001 | 28 | |
| 10 | 2001 | 23 | |
| 11 | Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir. | 1997 | 23 |
| 12 | 1996 | 18 | |
| 13 | 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene. | 1998 | 13 |
| 14 | 1998 | 4 |
About Iris Morr
Iris Morr is a scholar working on Genetics, Oncology, Pathology and Forensic Medicine, Epidemiology and Molecular Biology, having authored 14 papers that have together received 554 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Diet and metabolism studies (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Bone and Joint Diseases (1 paper), Amino Acid Enzymes and Metabolism (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Genetics (208 citations), Radiology, Nuclear Medicine and Imaging (140 citations), Biotechnology (56 citations), Cancer Research (79 citations) and Molecular Biology (213 citations). Iris Morr has collaborated with scholars based in Germany and Austria. Frequent co-authors include Uwe Haberkorn, Annette Altmann, G. van Kaick, Franz Oberdorfer, Shiming Jiang, Matthias E. Bellemann, J. Blatter, Uwe Haberkorn, Marcus Henze and Gunnar Brix. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Magnetic Resonance in Medicine, Nuclear Medicine and Biology, Gene Therapy and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.